HomeSPRO • NASDAQ
add
Spero Therapeutics Inc
Previous close
$1.95
Day range
$1.89 - $1.99
Year range
$0.51 - $3.22
Market cap
106.92M USD
Avg Volume
621.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 14.19M | 39.15% |
Operating expense | 5.88M | 6.24% |
Net income | -1.70M | 90.48% |
Net profit margin | -11.98 | 93.16% |
Earnings per share | — | — |
EBITDA | -2.36M | 87.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.19M | -50.90% |
Total assets | 62.12M | -58.55% |
Total liabilities | 29.29M | -57.78% |
Total equity | 32.83M | — |
Shares outstanding | 56.28M | — |
Price to book | 3.36 | — |
Return on assets | -8.44% | — |
Return on capital | -15.91% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.70M | 90.48% |
Cash from operations | -17.69M | 5.61% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -17.69M | 5.61% |
Free cash flow | -17.40M | -155.86% |
About
Founded
2013
Website
Employees
32
